KLYG (Kelyniam Global) Total Liabilities: $0.15 Mil (As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kelyniam Global Total Liabilities?

Kelyniam Global KLYG +4.82% Total Liabilities is $0.15 Mil as of Mar. 2008.

Kelyniam Global's Total Liabilities for the quarter that ended in Mar. 2008 was $0.15 Mil.

Kelyniam Global's quarterly Total Liabilities increased from Sep. 2007 ($0.12 Mil) to Dec. 2007 ($0.14 Mil) and increased from Dec. 2007 ($0.14 Mil) to Mar. 2008 ($0.15 Mil).

Kelyniam Global's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2006 ($0.11 Mil) and increased from Dec. 2006 ($0.11 Mil) to Dec. 2007 ($0.14 Mil).

Kelyniam Global Total Liabilities Historical Data

* Premium members only.

The historical data trend for Kelyniam Global's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kelyniam Global Total Liabilities Chart

Kelyniam Global Annual Data
Trend Dec06 Dec07
Total Liabilities
0.11 0.14

Kelyniam Global Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Total Liabilities Get a 7-Day Free Trial 0.10 0.12 0.12 0.14 0.15

Kelyniam Global Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kelyniam Global's Total Liabilities for the fiscal year that ended in Dec. 2007 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.117+(0.023+6.9388939039072E-18
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.14

Total Liabilities=Total Assets (A: Dec. 2007 )-Total Equity (A: Dec. 2007 )
=0.068--0.072
=0.14

Kelyniam Global's Total Liabilities for the quarter that ended in Mar. 2008 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.124+(0.021+-1.0408340855861E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.15

Total Liabilities=Total Assets (Q: Mar. 2008 )-Total Equity (Q: Mar. 2008 )
=0.063--0.082
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.15 Mil mean?
Kelyniam Global (KLYG) has a Total Liabilities of $0.15 Mil as of Mar. 2008. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kelyniam Global and its competitors.
Is Kelyniam Global's Total Liabilities too high?
Kelyniam Global's current Total Liabilities is $0.15 Mil.
How does Kelyniam Global's Total Liabilities compare to VASO and WCUI?
Kelyniam Global's Total Liabilities of $0.15 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kelyniam Global and its competitors. Kelyniam Global's current Total Liabilities is $0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelyniam Global stock overvalued right now?
Kelyniam Global (KLYG) has a current Total Liabilities of $0.15 Mil. The current Total Liabilities is $0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kelyniam Global (KLYG), the current Total Liabilities is $0.15 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kelyniam Global Business Description

Address 97 River Road, Suite A, Canton, CT, USA, 06019
Kelyniam Global Inc specializes in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer aided manufacturing of developed medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.